Skip to main content
Premium Trial:

Request an Annual Quote

Texas A&M Wins $12.3M Defense Contract

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute for Genomic Medicine (TIGM) at Texas A&M University said today that it has won a contract totaling $12.3 million from the US Department of Defense to screen potential targets that can be used to combat biothreats such as viral and bacterial pathogens and toxins.

The funding from the Defense Threat Reduction Agency (DTRA) will be used to develop high-throughput screening measures in mouse stem cells to discover new vaccines and therapies to counter serious biothreats.

Researchers at TIGM plan to screen over 3,500 different genes to find those that enable microbes and toxins to harm cells and tissues. When those candidates are identified, TIGM will use those to develop therapies to be tested in tissues and pre-clinical models, the university said.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.